Russian sovereign wealth fund, others invest in Alium pharmaceutical firm

Reuters, 09.07.2019

MOSCOW, July 9 (Reuters) - Russia's RDIF sovereign wealth fund and a consortium of investors including the Russia-China Investment Fund (RCIF) and leading Middle Eastern funds have acquired a 28% stake in pharmaceutical holding company Alium, RDIF said on Tuesday.

Alium was created by a merger of the Obolenskoe and Binnopharm pharmaceutical companies, RDIF said in a statement.